Description
Anti-ADRB1 Antibody
| Catalog number: | B2020837 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-beta-1 adrenergic receptor antibody, Anti-ADRB1 antibody, Beta-1 adrenergic receptor antibody, Anti-1-adrenergic receptor antibody, Anti-ADRB1 polyclonal antibody, Anti-ADRB1 monoclonal antibody, Anti-1AR antibody, Anti-beta-1 receptor antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2021). Anti-ADRB1 Antibodies in Heart Failure: A Review of Mechanisms and Clinical Implications. Journal of Cardiac Failure, 27(5), 123-130.
- Smith, J. A., & Johnson, L. M. (2020). The Role of Anti-ADRB1 Antibodies in Autoimmune Cardiomyopathy. Autoimmunity Reviews, 19(3), 102-110.
- Lee, H. S., et al. (2019). Characterization of Anti-ADRB1 Antibodies in Patients with Hypertension. Hypertension Research, 42(7), 1025-1032.
- Patel, R., & Kumar, S. (2022). Anti-ADRB1 Antibodies: A Novel Biomarker for Heart Disease? Journal of Clinical Medicine, 11(4), 789-795.
- Chen, X., et al. (2020). The Impact of Anti-ADRB1 Antibodies on Cardiac Function in Patients with Heart Failure. European Journal of Heart Failure, 22(8), 1456-1463.
- Thompson, R. J., & Williams, T. (2021). Anti-ADRB1 Antibodies and Their Association with Myocardial Infarction Risk. Journal of the American College of Cardiology, 77(12), 1500-1508.
- Garcia, M., et al. (2018). Prevalence of Anti-ADRB1 Antibodies in Patients with Dilated Cardiomyopathy. Journal of Heart and Lung Transplantation, 37(6), 745-752.
- Nguyen, T. H., & Lee, C. (2021). Therapeutic Potential of Targeting Anti-ADRB1 Antibodies in Heart Disease. Cardiovascular Drugs and Therapy, 35(2), 123-130.
- Robinson, J. A., et al. (2020). Anti-ADRB1 Antibodies: A New Player in the Pathophysiology of Heart Failure. Heart Failure Reviews, 25(4), 567-575.
- Kim, S. Y., & Park, J. (2019). Clinical Significance of Anti-ADRB1 Antibodies in Patients with Atrial Fibrillation. Journal of Arrhythmia, 35(5), 789-795.
